Page last updated: 2024-08-23

raloxifene hydrochloride and Colonic Neoplasms

raloxifene hydrochloride has been researched along with Colonic Neoplasms in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (33.33)29.6817
2010's2 (66.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Brewer, M; Bryant, T; Janakiram, NB; Lightfoot, S; Mohammed, A; Rao, CV; Steele, VE; Zhang, Y1
Janakiram, NB; Rao, CV; Steele, VE1
Achilefu, S; Akers, W; Gu, Y; Li, H; Ma, Y; Tian, J; Tu, Z1

Other Studies

3 other study(ies) available for raloxifene hydrochloride and Colonic Neoplasms

ArticleYear
Chemopreventive efficacy of raloxifene, bexarotene, and their combination on the progression of chemically induced colon adenomas to adenocarcinomas in rats.
    Cancer prevention research (Philadelphia, Pa.), 2013, Volume: 6, Issue:12

    Topics: Adenocarcinoma; Adenoma; Adult; Aged; Animals; Anticarcinogenic Agents; Apoptosis; Azoxymethane; Bexarotene; Biomarkers, Tumor; Blotting, Western; Colonic Neoplasms; Drug Therapy, Combination; Estrogen Antagonists; Estrogen Receptor beta; Female; Humans; Immunoenzyme Techniques; Male; Middle Aged; Neoplasm Grading; Raloxifene Hydrochloride; Rats; Rats, Inbred F344; Real-Time Polymerase Chain Reaction; Retinoid X Receptors; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Tetrahydronaphthalenes; Tissue Array Analysis; Tumor Cells, Cultured

2013
Estrogen receptor-beta as a potential target for colon cancer prevention: chemoprevention of azoxymethane-induced colon carcinogenesis by raloxifene in F344 rats.
    Cancer prevention research (Philadelphia, Pa.), 2009, Volume: 2, Issue:1

    Topics: Animals; Antineoplastic Agents; Azoxymethane; Blotting, Western; Carcinogens; Cell Line, Tumor; Chemoprevention; Colonic Neoplasms; Estrogen Receptor beta; Humans; Immunohistochemistry; Intestinal Mucosa; Male; Maximum Tolerated Dose; Raloxifene Hydrochloride; Rats; Rats, Inbred F344; Reverse Transcriptase Polymerase Chain Reaction

2009
Estrogen receptor β potentiates the antiproliferative effect of raloxifene and affects the cell migration and invasion in HCT-116 colon cancer cells.
    Journal of cancer research and clinical oncology, 2012, Volume: 138, Issue:7

    Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Movement; Cell Proliferation; Colon; Colonic Neoplasms; Dependovirus; Estrogen Receptor beta; Genetic Vectors; HCT116 Cells; Humans; Mice; Mice, Nude; Raloxifene Hydrochloride; Transfection; Xenograft Model Antitumor Assays

2012